Fibralign Corporation — Department of Defense SBIR Phase I: DHP14-009
Fibralign Corporation — SBIR Phase I award from Department of Defense.
- Amount
- $150,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Topic
- DHP14-009
- Solicitation
- 2014.1
- NAICS
- —
- Place of performance
- CA
- Period
- 2015-03-01 → 2015-09-30
Description
Traumatic injury leading to hemorrhage damage and ischemia is a significant cause of morbidity and mortality in wounded warfighters. Particularly significant is the loss of the microvasculature. We propose to enhance and guide neovascularization using novel plasmid-activated scaffolds. Such scaffolds are formed of multi-lumenal threads made from aligned